about 15,000 Da; 1 cST = 10-6 m2/sec].
indicates that this compound exhibits toxicity comparable to these other agents." Conventional toxicity tables (8, 9) compar- ing LD50 values show that the ip LD for sodium chloride is 4 g/kg. Thus, ordinary table salt is more toxic than either CS-D4 or breast implant distillate! To further put this into perspective relative to silicone breast implants, it would take about two 660-pound breast implants in an average size women to achieve a dose equivalent to the LD50 reported for CS-D4 by Lieberman et al. (1) . This is based on the unrealistic assumption that all of the CS-D4 in an implant would be released at one time.
The histopathologic findings reported by Lieberman et al. (1) are an enigma. Tables 2 and 3 in their paper show the reported histopathologic changes and average grade of the reported lesions for implant distillate and CS-D4, respectively. The findings reported in these tables are clearly not dose related. For example, in Table 2 (1), the highest incidence (3 of 6 animals) of extensive necrosis was produced by the lowest dose (3.5 g/kg), which had the lowest incidence (1 of 6 animals) of individual cell necrosis. Conversely, a dose of 35 g/kg had a 1-of-6 incidence of extensive necrosis and a 5-of-6 incidence of individual cell necrosis. Further, the increases reported by Lieberman et al. (1) for the three liver enzymes ( Figure 3A and B (11) provide compelling evidence that CS-D4 (and probably other cyclosiloxanes) are extensively metabolized by rats and that metabolism and subsequent elimination of hydrophilic metabolites in urine and feces is an important clearance mechanism from mammalian species. In particular, the rates of metabolism and clearance of CS-D4 and its metabolites (5, 6) suggest that these compounds will not be unusually persistent in mammalian organisms and are inconsistent with the suggestion by Lieberman et al. (1) that these compounds will persist in mice for "at least a year..." in a number of organs and fat.
In summary, this paper [Lieberman et al. (1) (1) also compared the toxicity of the cyclosiloxanes to the toxicity of carbon tetrachloride and trichloroethylene. Carbon tetrachloride has been identified as moderately toxic to laboratory animals (5), and trichloroethylene called relatively nontoxic (6) . Clearly, there is a considerable discrepancy between the usual toxicity classification and the descriptors used by Lieberman et al. (1) .
It is also not justified to ascertain that cyclosiloxanes are widely distributed following subcutaneous injection. In their previous paper (2), Lieberman and colleagues deposited 250 mg of breast implant distillate subcutaneously in the suprascapular area of mice. They then measured total and individual cyclosiloxanes in 10 organs and tissues up to 1 year after treatment. Again, the data are credible. Unfortunately, however, the paper (2) fails to provide data on mass balance, which is considered to be a de rigeur requirement in distribution studies. Nevertheless, from Figure 2B [Kala et al. (2) ] it can be estimated that the average concentration of total cyclosiloxanes 6 weeks after the injection, when maximum values were obtained, is approximately 6 pg/g wet tissue. Assuming that there is a uniform concentration of cyclosiloxanes in all tissues (an assumption which overlooks the fact that the highest cyclosiloxane concentrations were found in tissues which contribute little to overall body mass such as lymph nodes, uterus, and ovaries, whereas liver had < 1 pg/g and skeletal muscle approximately 6 pg/g), it then can be calculated that the total body burden away from the site of injection in a 25-g mouse would have been 150 pg cyclosiloxanes. This represents < 0.1% of all the material deposited in the suprascapular region. Where is the rest of the material? In the absence of a mass balance sheet that would provide complete data on distribution (and possible excretion) of the cyclosiloxanes, we must assume that > 99.9% of the injected material never left the site of deposition. Given these facts, it simply cannot be stated that "they are distributed widely." They are not.
The available evidence on the toxicity of silicones was recently reviewed by two independent bodies (7, 8) . The National Science Panel (7) To verify the statements, we recently performed a placebo-controlled study on intestinal absorption of siloxanes in rats (4) . We examined the blood of Wistar rats fed 12 days with a granulated feed diet without siloxanes (LSM; Wytwornia Pasz w Motyczu, Poland) with added 5% PDMS (n = 5 animals), 5% cPDMS oil (n = 5), or without siloxanes (n = 5). Viscosity and molecular mass of siloxanes tested were equal to those most frequently used in oral drugs [viscosity of 300 centistokes (cST), which reflects molecular mass of
